Baldin, G., Ciccullo, A., Capetti, A., Rusconi, S., Sterrantino, G., Cossu, M., Giacomelli, A., Lagi, F., Latini, A., Bagella, P., De Luca, A., Di Giambenedetto, S., & Madeddu, G. (2019). efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study. HIV medicine, 20(2), 164–168. http://access.bl.uk/ark:/81055/vdc_100076793220.0x000028